课题基金 / 基金详情

The multistep process in skin carcinogenesis

The multistep process in skin carcinogenesis
皮肤癌发生的多步骤过程
批准号:
13670888
负责人:
KUBO Yoshiaki
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

KUBO Yoshiaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Normal keratinocytes in human epidermis can convert to Squamous cell carcinoma (SCC) through the multistep process that involves activation of proto-oncogenes. However, the process in SCC is currently unknown. To elucidate the process, we tried keratinocytes. Using high efficiebcy retrovial transductions in primary keratinocytes, we expressed RasV12, P53w248, CDK (Cyclin dependent kinase) 4, and Htert either singly or in combination and used these cells to regenerate human skin on SCID mine. Within 3 weeks Ras-CDK4 produced human skin tumors with histologic features of SCC. Ras-CDK4 tumors, similar to human SCC, express increased levels of Cyclin D1, MMP2, and VEGF. Cyclin D1 was necessary but not sufficient for Ras-CDK4 neoplasia as CDK4-D1 failed to induce tumors while an anti-sense D1 retrovector that suppressed D1 tissue protein expression abolished Ras-CDK4 neoplasia. CDK4 synergy with Ras is dependent on intrinsic CDK4 kinase function as the kinase-dead N158 CDK4 point mutant failed to induce neoplasia when co-expressed with Ras. These data identify Ras and CDK4 as capable of converting normal human epidermal tissue into invasive neoplasia and indicate that functional CDK4-D1 is necessary for this process.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Dajee M..et al.: "NF-kB blockade and oncogenic Ras trigger invasive human epidermal neoplasia"Nature. 421. 639-643 (2003)
Dajee M..等人:“NF-kB 阻断和致癌 Ras 引发侵袭性人类表皮肿瘤”Nature。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Dajee M. et al.: "NF-κB blockade and Oncogenic Ras trigger invasive human epidermal neoplasia"Nature. 421. 639-643 (2003)
Dajee M. 等人:“NF-κB 阻断和致癌 Ras 引发侵袭性人类表皮肿瘤”,《自然》,421. 639-643 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Lazaror,M etal.: "CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis"Nature Medicine. 8-10. 1105-1114 (2002)
Lazaror,Metal.:“CDK4 与 Ras 共表达会导致恶性人类表皮肿瘤发生”《自然医学》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Lazarov M. et al.: "CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis"Nature Medicine. 8(10). 1105-1114 (2002)
Lazarov M. 等人:“CDK4 与 Ras 共表达会导致恶性人类表皮肿瘤发生”《自然医学》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Reprogramming of epidermal keratinocytes and the process of tumorigenesis
  • 批准号:
    16K10159
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2016
  • 负责人:
    KUBO Yoshiaki
  • 依托单位:
Genomic instabilities and tumorigenesis in epidermal keratinocytes
  • 批准号:
    25461696
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.16万
  • 财政年份:
    2013
  • 负责人:
    KUBO Yoshiaki
  • 依托单位:
Epigenetics abnormalities andescape fromthe immune system in epidermal keratinocytes
  • 批准号:
    22591224
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2010
  • 负责人:
    KUBO Yoshiaki
  • 依托单位:
The regulation and abnormalities of the epigenetics on epidermal keratinocytes
  • 批准号:
    19591309
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.75万
  • 财政年份:
    2007
  • 负责人:
    KUBO Yoshiaki
  • 依托单位:
国内基金
海外基金
金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
  • 批准号:
    2026JJ81256
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李弘德
  • 依托单位:
槲皮素基于P53/Ras调控细胞凋亡增殖抗OSF癌变的机制研究
  • 批准号:
    2026JJ82512
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王韧
  • 依托单位:
lncRNA H19通过介导Ras/ULK1信号影响乳腺癌细胞线粒体稳态及糖酵解的作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    施文标
  • 依托单位:
组织驻留菌Eggerthella lenta 通过代 谢重编程Ras通路介导的细胞凋亡抑制结 直肠癌的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    陈一纬
  • 依托单位: